Evidence map›Paper›PMID 25863938›Full record

ArticleMedical science monitor : international medical journal of experimental and clinical research2015

Transduced PEP-1-heme oxygenase-1 fusion protein reduces remote organ injury induced by intestinal ischemia/reperfusion.

Xiang-Hu He, Qing-Wen Li, Yan-Lin Wang, Zong-Ze Zhang, Jian-Juan Ke, Xue-Tao Yan, Kai Chen

Open access · hybridAbstract read
In one paragraph

Article in Medical science monitor : international medical journal of experimental and clinical research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Puerarin Attenuates Anoxia/Reoxygenation Injury Through Enhancing Bcl-2 Associated Athanogene 3 Expression, a Modulator of Apoptosis and Autophagy.Medical science monitor : international medical journal of experimental and clinical research · 2016
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Xiang-Hu HeDepartment of Anesthesiology, Zhongnan Hospital, Wuhan University, Wuhan, Hubei, China (mainland).
Qing-Wen LiDepartment of Anesthesiology, Zhongnan Hospital, Wuhan University, Wuhan, Hubei, China (mainland).
Yan-Lin WangDepartment of Anesthesiology, Zhongnan Hospital, Wuhan University, Wuhan, Hubei, China (mainland).
Zong-Ze ZhangDepartment of Anesthesiology, Zhongnan Hospital, Wuhan University, Wuhan, Hubei, China (mainland).
Jian-Juan KeDepartment of Anesthesiology, Zhongnan Hospital, Wuhan University, Wuhan, Hubei, China (mainland).
Xue-Tao YanDepartment of Anesthesiology, Shenzhen Boan Maternity and Child Health Hospital, Shenzhen, Guangdong, China (mainland).
Kai ChenDepartment of Anesthesiology, Zhongnan Hospital, Wuhan University, Wuhan, Hubei, China (mainland).
Wuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA fusion protein composed of heme oxygenase-1 (HO-1) and cell-penetrating peptide PEP-1 has been shown to reduce local intestinal injury after intestinal ischemia/reperfusion (I/R). In this study, we investigated the effects of PEP-1-HO-1 fusion protein on remote organ injury induced by intestinal I/R in rats. MATERIAL AND

methodsWe randomly assigned 24 male Sprague-Dawley rats to 3 groups: Sham, I/R, and I/R plus PEP-1-HO-1 treatment (HO). The model of intestinal I/R was established by occluding the superior mesenteric artery for 45 min followed by 120-min reperfusion. In HO group, PEP-1-HO-1 was administered intravenously 30 min before ischemia, while animals in the Sham and I/R groups received the equal volume of physiological saline. At the end of the experiment, lung, liver, and blood samples were collected and analyzed.

resultsMalondialdehyde levels and histological injury scores were increased, and superoxide dismutase activities were decreased in the lung and liver tissues in the I/R group compared with the Sham group (P<0.05). Serum levels of alanine aminotransferase, aspartate aminotransferase, tumor necrosis factor-α, interleukin-6, and lung tissue wet weight to dry weight ratio were increased in the I/R group compared with the Sham group (P<0.05). NF-κB expression in intestinal tissues was significantly higher in the I/R group than in the Sham group. These changes were significantly reversed by treatment with PEP-1-HO-1.

conclusionsThis study demonstrates that administration of PEP-1-HO-1 has a protective role against lung and liver injury after intestinal I/R, attributable to the reduction of released proinflammatory cytokines regulated by NF-κB.

Indexed as

Transduction, GeneticAlanine TransaminaseAnimalsAspartate AminotransferasesHeme Oxygenase-1Interleukin-6IntestinesLiverLungMaleMalondialdehydeNF-kappa BOrgan SizeRats, Sprague-DawleyRecombinant Fusion ProteinsReperfusion InjuryAlanine TransaminaseAspartate AminotransferasesHeme Oxygenase-1Interleukin-6MalondialdehydeNF-kappa BPEP-1-heme oxygenase-1 fusion proteinRecombinant Fusion ProteinsSuperoxide DismutaseTumor Necrosis Factor-alpha

Identifiers

PMID25863938
PMCPMC4404748
OpenAlexW2076849779

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.